Latest Molecular neuroscience Stories
Those of us with little patience may not have enough serotonin in our brains, as a new study in the journal Current Biology has linked the neurotransmitter to increased ability to wait in lab mice.
Working the serotonin dependent digestive system is the modulation focus in this Publius gut update.
Follows Positive Phase 2 Data Showing Rapid, Robust and Sustained Antidepressant Effect of Adjunctive GLYX-13 in Patients with Major Depressive Disorder EVANSTON, Ill., Dec.
Scratching an itch should make you feel better, but often times it only intensifies the feeling – and now scientists from Washington University School of Medicine in St. Louis have discovered what is responsible for this paradox.
The article published in AIMS Neuroscience explains how cortical microcircuitry is conducive to column formation.
Research presented by Dr. Lynn Raymond, from the University of British Columbia, shows that blocking a specific class of glutamate receptors, called extrasynaptic NMDA receptors, can improve motor learning and coordination, and prevent cell death in animal models of Huntington disease.
A molecular compound developed by Saint Louis University scientists restored learning, memory and appropriate behavior in a mouse model of Alzheimer's disease.
Alzheimer's disease, the primary cause of dementia in the elderly, imposes a tremendous social and economic burden on modern society.
Researchers studying peptides using the Gordon supercomputer at the San Diego Supercomputer Center (SDSC) at the University of California, San Diego have found new ways to elucidate the creation of the toxic oligomers associated with Alzheimer’s disease.
Alzheimer's disease has long been marked by progress -- but not the kind of progress the medical community seeks. It is the most common form of dementia among older Americans, and its risk increases with increasing age